Search for: "AVENTIS PHARMACEUTICALS, INC.,"
Results 81 - 100
of 219
Sort by Relevance
|
Sort by Date
25 May 2011, 8:52 pm
Therasense, Inc. v. [read post]
15 May 2011, 2:54 pm
LLC, Watson Pharmaceuticals, Inc., and Synthon Holding B.V. notifying them that the Bureau believes the companies violated federal law by failing to inform antitrust authorities about patent agreements involving Sanofi’s insomnia drug AMBIEN CR (zolpidem tartrate) Tablets, but that instead of recommending that the FTC take enforcement action, it would issue advisory letters. [read post]
10 May 2011, 4:24 pm
LLC, Watson Pharmaceuticals, Inc., and Synthon Holding B.V., that it believes the companies violated federal law by failing to inform antitrust authorities about drug patent agreements involving Sanofi's insomnia drug Ambien CR. [read post]
28 Apr 2011, 3:18 pm
By now Restatement (Second) of Torts §402A (1965) is so old as to be thought of as somewhat antediluvian. [read post]
2 Apr 2011, 11:58 pm
Sanofi-Aventis sued Sun Pharmaceutical for its generic mimic of a cancer treatment drug, oxaliplatin. [read post]
27 Mar 2011, 6:28 pm
Jones Ward PLC attorney Larry Jones filed a lawsuit this week against pharmaceutical giant sanofi-aventis U.S., Inc. [read post]
15 Mar 2011, 3:52 pm
Judge Susan Illston recently granted summary judgment on a few claims but left others for trial in a massive pharmaceutical patent case between Sanofi-Aventis Deutchland GMBH (Sanofi, plaintiff), Genentech, Inc. [read post]
18 Feb 2011, 11:47 am
The defendants in both sets of actions were Sanofi Aventis and Sanofi-Synthelabo, Inc., Bristol-Myers Squibb Company and Bristol-Myers Squibb Sanofi Pharmaceuticals Holding Partnership (collectively “Sanofi”) and Apotex Corporation (“Apotex”). [read post]
8 Feb 2011, 10:51 pm
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
8 Feb 2011, 7:19 am
Glenmark Pharmaceuticals Inc., USA, et. al., 2-07-cv-05855 (NJD February 3, 2011, Order) (Cavanaugh, J.) [read post]
3 Feb 2011, 2:11 pm
Mylan Pharmaceuticals., Inc., 696 F. [read post]
30 Jan 2011, 5:29 pm
National Rehab Partners Inc. [read post]
20 Jan 2011, 12:50 pm
Sandoz Pharmaceuticals Corp., 487 S.E.2d 70, 74 (Ga. [read post]
30 Dec 2010, 5:48 am
Karst – Amphastar Pharmaceuticals Inc. [read post]
29 Dec 2010, 2:57 am
Ferring Pharmaceuticals, Inc et al. [read post]
26 Dec 2010, 9:59 pm
Sandoz, Inc., the Federal Circuit vacated the entry of a consent judgment and an injunction by the District Court for the District of New Jersey, which enjoined Defendants-Appellants Sun Pharmaceutical Industries, Ltd. and Caraco Pharmaceutical Laboratories, Ltd. [read post]
14 Dec 2010, 7:06 pm
Karst – When we last left you in the battle over FDA’s approval of a generic version of sanofi-aventis U.S. [read post]
8 Dec 2010, 6:07 pm
Other GnRH drugs include Watson Pharmaceuticals Inc's Trelstar and Endo Pharmaceuticals Holdings Inc's Vantas. [read post]
23 Nov 2010, 2:19 am
Watson Pharmaceuticals, Inc., D2010-0800 (WIPO August 31, 2010). [read post]
3 Nov 2010, 7:00 am
Walters On October 25, Amphastar Pharmaceuticals, Inc. [read post]
